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Abstract
A number of studies have been conducted to investigate the predictive value of common genetic variants for
complex diseases. To date, these studies have generally shown that common variants have no appreciable added
predictive value over classical risk factors. New sequencing technology has enhanced the ability to identify rare
variants that may have larger functional effects than common variants. One would expect rare variants to improve
the discrimination power for disease risk by permitting more detailed quantification of genetic risk. Using the
Genetic Analysis Workshop 17 simulated data sets for unrelated individuals, we evaluate the predictive value of rare
variants by comparing prediction models built using the support vector machine algorithm with or without rare
variants. Empirical results suggest that rare variants have appreciable effects on disease risk prediction.
Background
The potential of common genetic variants detected from
genome-wide association studies to predict the risk of
complex diseases has been investigated in a steadily
increasing number of empirical studies. So far, these stu-
dies generally show limited predictive value of genetic fac-
tors [1-4]. This finding might be due to the use of only a
limited number of confirmed susceptibility loci. However,
a prediction model built using the support vector machine
(SVM) algorithm achieves improved performance when a
large number of single-nucleotide polymorphisms (SNPs)
are included in the prediction models [5].
Recently, substantial advances have taken place in devel-
oping new sequencing technologies (e.g., ABI/SOLiD,
Roche/454, and Illumina/Solexa) [6]. Sequencing of candi-
date genes, exons, or whole genomes will allow the identi-
fication of rare susceptibility variants that may have
stronger effects on disease susceptibility [3]. Although
more and more rare variants have been found to be asso-
ciated with complex diseases [7,8], it is still unclear
whether rare variants will improve disease risk prediction.
The aim of this study is to determine whether rare var-
iants provide valuable predictive information beyond that
provided by common variants and environmental covari-
ates alone. To this end, we examine the effect of adding
collapsed rare SNPs to prediction models that include
both environmental covariates and common genetic var-
iants in the Genetic Analysis Workshop 17 (GAW17)
simulation data sets. The prediction models are built using
an SVM algorithm [5,9,10], which uses biomarkers that
have reached a predefined statistical threshold for associa-
tion with the disease. As discussed by Wei et al. [5], the
SVM-based risk prediction algorithm, which is inherently
capable of handling intermarker correlation structure, can
generate consistent and robust prediction models across
different data sets.
Methods
Data
The first data set of GAW17 consists of a collection of
697 unrelated individuals from the 1000 Genomes Pro-
ject. There are 200 replicates of simulated trait informa-
tion and a number of nongenetic covariates such as age,
sex, and smoking status. SNP genotypes were obtained
from the sequence alignment files provided by the 1000
Genomes Project for their pilot3 study [11]. Included are
24,487 autosomal SNPs from 3,205 genes.
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To assess the effect of rare variants on global disease risk
prediction, we consider prediction models built using an
SVM algorithm. The SVM is one of the popular classifiers
in the field of machine learning and delivers state-of-the-
art performance in a wide variety of biological applications
[5]. In essence, the SVM is a supervised learning method
that produces nonlinear boundaries by constructing a lin-
ear boundary in a transformed version (kernel function) of
the feature space (SNP genotypes); thus it achieves maxi-
mum separation between two classes of subjects (case
group vs. control group). Unlike traditional regression-
based methods, the SVM is particularly useful in classify-
ing high-dimensional data by allowing more input fea-
tures, such as SNPs or genes. We include in the prediction
model those genetic variants with p-values less than a pre-
specified threshold from association analysis, with adjust-
ment for covariates. Here, rare variants are defined as
SNPs with minor allele frequency (MAF) less than 5%
[12,13].
The association between disease and common SNPs
(MAF ≥ 5%) is evaluated using Fisher’s exact test by com-
paring allele counts between case subjects and control
subjects. SNPs with p-values less than a prespecified
threshold (e.g., 1.0 × 10
−3) are used for disease risk
assessment in the next step. For the analysis of rare var-
iants (MAF < 5%), SNPs are first collapsed by the pre-
sence or absence of minor alleles within each gene in
each individual [14-17]. For each gene, we consider two
sets of rare SNPs: the set of all rare variants and the set
of all nonsynonymous rare variants. The collapsing
approach is applied to each of the two sets. For each set
of variants, the disease status is modeled in a logistic
regression framework as a function of the presence or
absence of a rare allele in the SNP set. Genes reaching a
predefined statistical threshold are included in the risk
prediction model. For a gene for which both rare variant
sets reach the threshold, the set with the smaller Akaike
information criterion (AIC) is selected to model the
effect of rare variants in the gene. The p-value threshold
used to select variants ranged from 1.0 × 10
−5 to 0.01.
The SVM training algorithm is applied to these variants
and to the covariates Age, Sex, and Smoking status. The
genotype data for common SNPs are coded 0, 1, or 2,
reflecting the number of minor alleles. Rare variants are
coded 1 or 0, corresponding to the presence or absence,
respectively, of minor alleles within each gene. Prediction
models are built to discriminate between case subjects and
control subjects. The risk prediction model is built using
the SVM algorithm in the training data set, and the pre-
diction error of the model is assessed in the validation
data sets.
To evaluate the predictive value of rare variants, we con-
ducted two experimental studies. In the first experiment,
the set of SNPs included in the risk prediction model was
selected from the first trait replicate, and the prediction
model was built on the same data set. Prediction error was
assessed on the remaining 199 trait replicates. In the sec-
ond experiment, for each trait replicate we randomly
divided the data into a training set and a validation set.
SNP selection and risk prediction models were performed
on the training set, and prediction error was estimated
from the validation set. We repeated this procedure in
each of the 200 trait data sets. In this second experiment,
the size of the training set took values from 300 to 600,
with an increment of 100.
We used the R package e1071 to build the risk predic-
tion models. This package is an interface to the LIBSVM
implementation of the SVM algorithm (current version
3.0, http://www.csie.ntu.edu.tw/~cjlin/libsvm). We trained
the soft-margin linear SVM classifiers [18] in the training
data sets using the SVM penalty parameter C =1 ,t h e
default value of the R package.
To evaluate the performance of risk prediction models,
we applied receiver operating characteristic (ROC) curve
analysis to the validation data sets. The ROC is a widely
used tool to evaluate the discrimination ability of a binary
classifier. In ROC analysis, the discriminatory power of
the prediction model is usually measured as the area
under the ROC curve (AUC value). This is the probability
that a randomly chosen positive sample will have higher
predicted risk than that of a randomly chosen negative
sample. We compared the AUC values of prediction
models combining both common and rare variants with
the AUC values of models incorporating only common
variants.
Results
Seven p-value cut points were selected from 1.0 × 10
−5
to 0.01. All SNPs reaching the predefined threshold
were included in the prediction models. We evaluated
the prediction potential of rare variants by comparing
models including rare variants with models without rare
variants.
Table 1 shows the AUC values of models with both
common and rare variants and of models with common
variants, the differences in AUC values between models,
and 95% confidence intervals of these AUC value differ-
ences for the first experiment. The AUC values and the
AUC value differences are similar across different p-value
thresholds, despite the fact that a higher threshold allows
more genetic factors in the prediction model. This sug-
gests that adding less significant SNPs does not provide
sufficient improvement in discrimination power. In com-
paring the AUC values between models with and without
rare variants, we found that incorporation of rare variants
slightly improved the prediction. The improvement was
statistically significant if we compared the two AUC
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the improvement was relatively small (<0.4%).
In the first experiment, the prediction model was built
on the first trait replicate. We also evaluated the perfor-
mance of prediction models using other trait replicates
as a training set. Models built on different replicates
could choose quite different sets of genetic variants, but
the results of these models were similar to the results
shown in Table 1.
Table 2 presents the comparison results for the second
experiment. Within a fixed size of the training set, the
AUC value is larger for most of the prediction models as
Table 1 AUC values for models with and without rare variants in the first experiment
Variant selection p-value
threshold
Common variants
only
Common and rare
variants
AUC value difference with 95% confidence
interval
0.01 0.8057 0.8088 0.0031 (0.0028, 0.0034)
0.005 0.8063 0.8088 0.0025 (0.0023, 0.0027)
0.001 0.8056 0.8076 0.0020 (0.0019, 0.0021)
5.0 × 10
−4 0.8062 0.8080 0.0018 (0.0017, 0.0019)
1.0 × 10
−4 0.8075 0.8093 0.0017 (0.0017, 0.0018)
5.0 × 10
−5 0.8075 0.8092 0.0017 (0.0017, 0.0018)
1.0 × 10
−5 0.8079 0.8096 0.0017 (0.0016, 0.0017)
Prediction models were built on the first phenotype replication.
Table 2 AUC values for models with and without rare variants in the second experiment
Variant selection p-value
threshold
Common variants
only
Common and rare
variants
AUC value difference with 95% confidence
interval
Size of training set = 300
0.01 0.7901 0.8442 0.0541 (0.0520, 0.0562)
0.005 0.8014 0.8364 0.0350 (0.0329, 0.0372)
0.001 0.8199 0.8437 0.0239 (0.0227, 0.0250)
5.0 × 10
−4 0.8185 0.8429 0.0244 (0.0234, 0.0255)
1.0 × 10
−4 0.8191 0.8333 0.0142 (0.0136, 0.0148)
5.0 × 10
−5 0.8177 0.8310 0.0133 (0.0128, 0.0139)
1.0 × 10
−5 0.8124 0.8279 0.0154 (0.0150, 0.0159)
Size of training set = 400
0.01 0.8315 0.8857 0.0542 (0.0524, 0.0561)
0.005 0.8348 0.8724 0.0376 (0.0362, 0.0391)
0.001 0.8346 0.8590 0.0244 (0.0236, 0.0253)
5.0 × 10
-4 0.8301 0.8564 0.0263 (0.0256, 0.0270)
1.0 × 10
-4 0.8247 0.8393 0.0146 (0.0143, 0.0150)
5.0 × 10
-5 0.8219 0.8355 0.0135 (0.0132, 0.0139)
1.0 × 10
-5 0.8157 0.8313 0.0156 (0.0152, 0.0159)
Size of training set = 500
0.01 0.8616 0.9182 0.0565 (0.0551, 0.0579)
0.005 0.8572 0.8966 0.0394 (0.0384, 0.0404)
0.001 0.8443 0.8686 0.0244 (0.0238, 0.0249)
5.0 × 10
−4 0.8373 0.8636 0.0263 (0.0258, 0.0268)
1.0 × 10
−4 0.8280 0.8422 0.0142 (0.0139, 0.0145)
5.0 × 10
−5 0.8245 0.8378 0.0133 (0.0130, 0.0135)
1.0 × 10
−5 0.8177 0.8331 0.0154 (0.0152, 0.0157)
Size of training set = 600
0.01 0.8850 0.9470 0.0619 (0.0610, 0.0629)
0.005 0.8730 0.9149 0.0418 (0.0411, 0.0425)
0.001 0.8510 0.8754 0.0244 (0.0240, 0.0248)
5.0 × 10
−4 0.8420 0.8682 0.0262 (0.0259, 0.0265)
1.0 × 10
−4 0.8303 0.8443 0.0140 (0.0138, 0.0141)
5.0 × 10
−5 0.8259 0.8393 0.0133 (0.0132, 0.0135)
1.0 × 10
−5 0.8188 0.8342 0.0155 (0.0154, 0.0156)
Prediction models were built on a randomly selected training data set for each replicate.
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models perform better with more variants included in the
model. However, this relationship is not apparent when
the size of the training set is 300. With such a small train-
ing set, the estimation of association between disease and
variants is not accurate. A larger p-value threshold may
result in a higher proportion of false-positive variants
included in the prediction model, thus leading to smaller
AUC values.
In the second experiment, the differences between the
AUC values of models with rare variants and models with-
out rare variants were significant at the 0.05 level, and the
differences were much larger than the differences in the
first experiment. The largest AUC difference between two
models was more than 6%, suggesting a great potential for
the improvement of prediction models through incorpora-
tion of rare variants.
Discussion and conclusions
By using prediction models built on the GAW17 simu-
lated data sets and using the SVM algorithm, we con-
ducted two experiments to assess the value of rare
variants in complex disease risk prediction. In our stu-
dies, including rare variants marginally improved the
classification of risk prediction models in the first experi-
ment and substantially improved the classification in the
second experiment. In both experiments, rare variants
had an appreciable effect on disease risk prediction.
In the SVM literature, two kernel functions are com-
monly used: the linear kernel:
k(x, y)=x′y (1)
and the radial kernel:
k( , ) exp . xy x y =− − ( ) g
2 (1)
We applied both the radial kernel and the linear ker-
nel in our two experiments. The predictive values con-
tributed by rare variants were similar between the two
kernels. The results presented in this paper are limited
to the linear kernel for its good interpretability [5].
In addition, we used different penalty parameters, ran-
ging from 0.001 to 1000, to build the prediction models.
Although the SVM algorithm tends to assign different
weights for risk factors under different penalty parameters,
the performance of the prediction models are similar for
different penalty parameters. Results for the penalty para-
meter C = 1 are shown in this paper.
The AUC value is one of the popularly used statistics
for model comparison. We also computed other mea-
surements of discriminatory power for prediction models,
such as accuracy, true-positive rate, false-positive rate,
positive predictive value, and negative predictive value.
T h ed i f f e r e n c eb e t w e e nt h et w ot y p e so fp r e d i c t i o n
models have similar patterns to the results for the AUC
value (data not shown).
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